Thiazolidinedione Use is Associated with Improved All-Cause Mortality Compared with Sulfonylureas Among Diabetic Hemodialysis Patients

Ítems similars

• All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients
  per: Sattar, Abdus, et al.
  Publicat: (2012)
• Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes
  per: Brunelli, Steven M., et al.
  Publicat: (2009)
• Depression and All-Cause Mortality in Hemodialysis Patients
  per: Fan, Li, et al.
  Publicat: (2014)
• Hypomagnesemia and Mortality in Incident Hemodialysis Patients
  per: Li, Lin, et al.
  Publicat: (2015)
• Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients
  per: Suematsu, Yasunori, et al.
  Publicat: (2019)